Literature DB >> 11165886

Effect of glutamine supplementation of the diet on tissue protein synthesis rate of glucocorticoid-treated rats.

J J Boza1, M Turini, D Moënnoz, F Montigon, J Vuichoud, N Gueissaz, G Gremaud, E Pouteau, C Piguet-Welsch, P A Finot, O Ballèvre.   

Abstract

Although glutamine status in the critically ill patient can be improved by nutritional means, the most effective way of effecting such supplementation has received little attention. We evaluated two different ways of supplementing clinical nutrition products with glutamine, either with free glutamine or by providing a glutamine-rich protein source, in acute glucocorticoid-treated (intraperitoneal dexamethasone, 120 mg/kg) rats. During the recovery period, the animals received isonitrogenous and isoenergetic diets containing either casein, mixed whey proteins with or without glutamine, or carob protein plus essential amino acids. Plasma and tissue amino acids and glutathione as well as tissue protein synthesis were measured. Dexamethasone treatment lowered weight gain, muscle glutamine, and muscle and jejunal protein synthetic rate. Muscle protein synthesis was increased (from 15.9% to 24.2%/d) only when glutamine was included in the diet as a free amino acid. This increase paralleled a rise in plasma glutamine. We speculate that glutamine provided in dietary protein is extensively metabolized by the splanchnic tissues and does not influence peripheral glutamine status to the same extent as glutamine provided in a free amino acid form. However, both forms of glutamine supplementation were equally effective in increasing protein synthesis in the jejunum (by 25%). This is likely the main benefit of glutamine supplementation of enteral nutrition formulas.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11165886     DOI: 10.1016/s0899-9007(00)00505-0

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  5 in total

1.  New insights in nutritional management and amino acid supplementation in urea cycle disorders.

Authors:  Fernando Scaglia
Journal:  Mol Genet Metab       Date:  2010-03-01       Impact factor: 4.797

2.  Ornithine alpha-ketoglutarate: could it be a new therapeutic option for sarcopenia?

Authors:  S Walrand
Journal:  J Nutr Health Aging       Date:  2010-08       Impact factor: 4.075

3.  Amelioration of radiation-induced acute inflammation and mucosal atrophy by beta-hydroxy-beta-methylbutyrate, L-glutamıne, and L-argınıne: results of an experimental study.

Authors:  Cagdas Yavas; Guler Yavas; Hilal Acar; Hatice Toy; Deniz Yuce; Serap Akyurek; Ozlem Ata
Journal:  Support Care Cancer       Date:  2012-09-21       Impact factor: 3.603

4.  Nutritional effect of oral supplement enriched in beta-hydroxy-beta-methylbutyrate, glutamine and arginine on resting metabolic rate after laparoscopic gastric bypass.

Authors:  Ronald H Clements; Neha Saraf; Manasi Kakade; Kishore Yellumahanthi; Merritt White; Jo Ann Hackett
Journal:  Surg Endosc       Date:  2010-10-17       Impact factor: 4.584

5.  Effect of glutamine supplementation on cardiometabolic risk factors and inflammatory markers: a systematic review and meta-analysis.

Authors:  Hamid Asayesh; Mostafa Qorbani; Motahareh Hasani; Asieh Mansour; Shirin Djalalinia; Armita Mahdavi Gorabi; Fatemeh Ochi
Journal:  BMC Cardiovasc Disord       Date:  2021-04-17       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.